Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chuan-Jin Wang, Heng-Zhi Wang & Wei Li. (2019) A novel conjunction of folate-targeted carbon nanotubes containing protohemin and oridonin-liposome loaded microbubbles for cancer chemo-sonodynamic therapy. Journal of Drug Targeting 27:10, pages 1076-1083.
Read now
Read now
Chuanjin Wang, Wei Li & Bingcheng Hu. (2017) The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system. Journal of Drug Targeting 25:1, pages 83-91.
Read now
Read now
Tao Liu, Rainer H Müller & Jan P Möschwitzer. (2015) Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension. Expert Opinion on Drug Delivery 12:11, pages 1741-1754.
Read now
Read now
Peng-Fei Yue, Hai-Long Yuan, Yong Liu, Jin Han & Pi-Min Teng. (2012) Preparation and Characterization of Ursodeoxycholic Acid Nanosuspension. Journal of Dispersion Science and Technology 33:7, pages 965-969.
Read now
Read now
Articles from other publishers (19)
Jialin Yao, Lu Liu, Qingxiang Sun & Xiaofei Shen. (2023) Direct cellular targets and anticancer mechanisms of the natural product oridonin. MedComm – Future Medicine 2:1.
Crossref
Crossref
Akanksha Patel & Abhay Dharamsi. (2021) Nanocrystals- A Substantial Platform for Drug Delivery Applications. Current Nanomedicine 11:4, pages 202-212.
Crossref
Crossref
Vijay Agarwal, Nitin Kaushik & Pankaj Kumar Sharma. (2021) Nanocrystal Approaches for Poorly Soluble Drugs and their Role in Development of Marketed Formulation. Drug Delivery Letters 11:4, pages 275-294.
Crossref
Crossref
Yuanyuan Zhang, Shaohua Wang, Mengmeng Dai, Jijuan Nai, Liqiao Zhu & Huagang Sheng. (2020) Solubility and Bioavailability Enhancement of Oridonin: A Review. Molecules 25:2, pages 332.
Crossref
Crossref
Lu Xu, Lei Li, Chen-Yang Zhang, Hermann Schluesener & Zhi-Yuan Zhang. (2019) Natural Diterpenoid Oridonin Ameliorates Experimental Autoimmune Neuritis by Promoting Anti-inflammatory Macrophages Through Blocking Notch Pathway. Frontiers in Neuroscience 13.
Crossref
Crossref
Brice Martin Couillaud, Philippe Espeau, Nathalie Mignet & Yohann Corvis. (2018) State of the Art of Pharmaceutical Solid Forms: from Crystal Property Issues to Nanocrystals Formulation. ChemMedChem 14:1, pages 8-23.
Crossref
Crossref
Flavia Fontana, Patrícia Figueiredo, Pei Zhang, Jouni T. Hirvonen, Dongfei Liu & Hélder A. Santos. (2018) Production of pure drug nanocrystals and nano co-crystals by confinement methods. Advanced Drug Delivery Reviews 131, pages 3-21.
Crossref
Crossref
Jianlei Lu, Xiang Chen, Shuang Qu, Bing Yao, Yuexin Xu, Jiahui Wu, Yucui Jin & Changyan Ma. (2017) Oridonin induces G2/M cell cycle arrest and apoptosis via the PI3K/Akt signaling pathway in hormone-independent prostate cancer cells. Oncology Letters 13:4, pages 2838-2846.
Crossref
Crossref
Ye Ding, Chunyong Ding, Na Ye, Zhiqing Liu, Eric A. Wold, Haiying Chen, Christopher Wild, Qiang Shen & Jia Zhou. (2016) Discovery and development of natural product oridonin-inspired anticancer agents. European Journal of Medicinal Chemistry 122, pages 102-117.
Crossref
Crossref
Ranjita Shegokar. 2016. Handbook of Nanoparticles. Handbook of Nanoparticles
385
406
.
Jie Yang, Hai Jiang, Chunyu Wang, Bo Yang, Lijun Zhao, Dongling Hu, Guihua Qiu, Xiaolin Dong & Bin Xiao. (2015) Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects. Biomedicine & Pharmacotherapy 72, pages 125-134.
Crossref
Crossref
Ranjita Shegokar. 2015. Handbook of Nanoparticles. Handbook of Nanoparticles
1
17
.
Vivek K. Pawar, Yuvraj Singh, Jaya Gopal Meher, Siddharth Gupta & Manish K. Chourasia. (2014) Engineered nanocrystal technology: In-vivo fate, targeting and applications in drug delivery. Journal of Controlled Release 183, pages 51-66.
Crossref
Crossref
Zhi‐Yuan Zhang, Rolf Daniels & Hermann J. Schluesener. (2013) Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis. Journal of Cellular and Molecular Medicine 17:12, pages 1566-1576.
Crossref
Crossref
Jan P. Möschwitzer. (2013) Drug nanocrystals in the commercial pharmaceutical development process. International Journal of Pharmaceutics 453:1, pages 142-156.
Crossref
Crossref
Shayne Cox GadChristin P. Hollis & Tonglei Li. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Shegokar Ranjita. (2013) Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases. Journal of Pharmaceutical Investigation 43:1, pages 1-26.
Crossref
Crossref
Chuan-Jin Wang, Guang-Jun Zhu, Li Yu & Bai-Hui Shi. (2013) Preparation, In Vitro, and In Vivo Antitumor Activity of Folate Receptor-Targeted Nanoliposomes Containing Oridonin. Drug Development Research 74:1, pages 43-49.
Crossref
Crossref
Yancai Wang, Yingying Ma, Ying Zheng, Ju Song, Xiao Yang, Chao Bi, Dianrui Zhang & Qiang Zhang. (2013) In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. International Journal of Pharmaceutics 441:1-2, pages 728-735.
Crossref
Crossref